Quarterly report pursuant to Section 13 or 15(d)

Grant Revenue (Details)

v3.20.1
Grant Revenue (Details) - USD ($)
1 Months Ended 3 Months Ended
Dec. 31, 2019
Oct. 31, 2017
May 31, 2017
Jun. 30, 2016
May 31, 2016
Mar. 31, 2020
Mar. 31, 2019
Grant Revenue              
Revenue           $ 901,880 $ 701,062
Remaining grant amount           $ 1,500,000  
Maximum              
Grant Revenue              
Royalty percentage after threshold is met           1.00%  
Pelican Therapeutics, Inc.              
Grant Revenue              
Amount awarded from CPRIT grant       $ 15,200,000 $ 15,200,000    
Contribution to be made by Pelican           $ 7,600,000  
Pelican Therapeutics, Inc. | Tranche I              
Grant Revenue              
Revenue     $ 1,800,000        
Pelican Therapeutics, Inc. | Tranche II              
Grant Revenue              
Revenue   $ 6,500,000          
Pelican Therapeutics, Inc. | Tranche III              
Grant Revenue              
Revenue $ 5,400,000            
Pelican Therapeutics, Inc. | Grant revenue              
Grant Revenue              
Revenue           11,200,000  
Amount the company is required to match of each dollar of grant           0.50  
Threshold amount for match of grant           $ 1.00